Clinical trial
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
NCT01658514 is registered in ClinicalTrials.gov with Elcelyx Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
- Lead sponsor
- Elcelyx Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- June 30, 2014
- Enrollment
- 39 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.